Autoimmune hepatitis surgery

Autoimmune hepatitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating autoimmune hepatitis differential diagnosis
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Diagnostic of choice
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Autoimmune hepatitis surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Autoimmune hepatitis surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Autoimmune hepatitis surgery
CDC on Autoimmune hepatitis surgery
Autoimmune hepatitis surgery in the news
Blogs on Autoimmune hepatitis surgery
Directions to Hospitals Treating Autoimmune hepatitis
Risk calculators and risk factors for Autoimmune hepatitis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Manpreet Kaur, MD [2]

Surgery

Liver Transplantation

Liver transplantation is indicated in the following condition:

• Medical therapy fails
• Decompensated chronic liver disease
• Fulminant hepatic failure
• Hepatocellular carcinoma
• MELD score of >15 or a Child-Pugh score of >10277

Five-year survival rates, following transplantation for AIH, is about 75% AH can recur in the transplanted liver despite aggressive immunosuppression.